2014
DOI: 10.1097/iae.0000000000000208
|View full text |Cite
|
Sign up to set email alerts
|

“En Face” Optical Coherence Tomography Imaging in Type 2 Idiopathic Macular Telangiectasia

Abstract: En face OCT is a noninvasive and reproducible technique that helps to better assess and follow up retinal and choroidal processes in Type 2 macular telangiectasia.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
10
0

Year Published

2016
2016
2022
2022

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 15 publications
(11 citation statements)
references
References 8 publications
1
10
0
Order By: Relevance
“…10,11,13,14,1618,26 While the pathophysiology of MacTel type 2 remains uncertain, it is hypothesized to be linked to Müller cell death or dysfunction, which leads to the resulting photoreceptor loss (and thus EZ disruption) and juxtafoveal capillary proliferation. 1,18 …”
Section: Discussionmentioning
confidence: 99%
“…10,11,13,14,1618,26 While the pathophysiology of MacTel type 2 remains uncertain, it is hypothesized to be linked to Müller cell death or dysfunction, which leads to the resulting photoreceptor loss (and thus EZ disruption) and juxtafoveal capillary proliferation. 1,18 …”
Section: Discussionmentioning
confidence: 99%
“…Moreover, this method is robust to small segmentation inaccuracies. At the same time, en face OCT requires image processing techniques that deal with the numerous confounding shadow artifacts unrelated to the atrophy [21, 22, [43][44][45], such as the large vessel shadow inaccurately segmented in [ Fig. 9 (DR3)].…”
Section: Discussionmentioning
confidence: 99%
“…Progression of the disease is characterised by shrinkage of the outer retinal layers and reduction in the central foveal thickness (CFT) 8. En face OCT also enables visualisation of the pigment plaques and new vessels in the various retinal layers along with the extent of associated exudation 5 9…”
Section: Introductionmentioning
confidence: 99%